GlassScriptPhysician profile
Joseph D Sweeney
NPI 1871547398
$5,891.63
in general payments reported to CMS, 2019-2025
5 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Blood Banking & Transfusion Medicine provider received nationally (typical 2025 total: $146).
See the full distribution for Blood Banking & Transfusion Medicine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.58 · 2020: $2,927 · 2023: $2,809 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,809 · Food and Beverage: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,808.75 |
| Food and Beverage | $104.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $2,906.62 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $2,808.75 | 2023 | |
| On Target Laboratories, INC | $104.04 | 2025 | Cytalux |
| Janssen Pharmaceuticals, INC | $72.22 | 2019-2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Sweeney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.